Epstein Secrets

irsten Gillibrand has been plagued by questions about her role as the first of three dozen Democratic senators to demand Franken's resignation. ... Gillibrand told me, `I'd do it again today,' adding, `If a few wealthy donors are angry about that, it's on them." Palm Beach County Sheriff's Office chief d

for his resignation. It was made in the heat of the moment, without concern for exactly what this was.' ... The Presidential candidacy of Senator Kirsten Gillibrand has been plagued by questions about her role as the first of three dozen Democratic senators to demand Franken's resignation. ... Gillibrand told

Ebola epidemic has killed more than 1,700 people. World Health Organization officials say they have 245,000 doses of an experimental vaccine from Merck that's already in use and that they need additional options. But health leaders in the Democratic Republic of Congo are reluctant to roll out the

l for his resignation. It was made in the heat of the moment, without concern for exactly what this was.' ... The Presidential candidacy of Senator Kirsten Gillibrand has been plagued by questions about her role as the first of three dozen Democratic senators to demand Franken's resignation. ... Gillibrand told m

irsten Gillibrand has been plagued by questions about her role as the first of three dozen Democratic senators to demand Franken's resignation. ... Gillibrand told me, 'I'd do it again today,' adding, 'If a few wealthy donors are angry about that, it's on them.- Palm Beach County Sheriff's Office chief de

t Ebola epidemic has killed more than 1,700 people. World Health Organization officials say they have 245,000 doses of an experimental vaccine from Merck that's already in use and that they need additional options. But health leaders in the Democratic Republic of Congo are reluctant to roll out the s

aid Monday that because the A.A.U. report was the first of its kind for Yale it was impossible to know whether those measures had paid off. Senator Kirsten Gillibrand, Democrat of New York, praised the study but expressed impatience that Congress had not acted to force colleges to improve their handling of sexual

huge profits. Gilead, maker of Sovaldi, has profits of around 5o percent. Biogen, Amgen and other biotech firms have profits of around 30 percent. Merck and Pfizer are seeing profits of 18 percent or more. Even if profits were cut by a third or a half, there would be sufficient incentive to assume th